Is Progression-Free Survival 2 Ready for Prime Time in US Food and Drug Administration Regulatory Decision Making?

Journal of Clinical Oncology 2026

View at publisher

Authors: Mallorie H. Fiero, Mirat Shah, Laleh Amiri-Kordestani

DOI: 10.1200/jco-26-00226

Cited by: 2

References: 7

Fields of Study & Subjects

Health Systems Economic Evaluations Quality of Life Economic and Financial Impacts of Cancer Advanced Causal Inference Techniques

References 7